COMPANY PROFILE // THE 014 REPORT
Pediatrix Medical Group, Inc.
MD (NYSE) · Formerly: MEDNAX, INC.
Assembled from 2 government sources in 0.4 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
No flag from the records checked. 25 of 26 lists and sources checked came back clear (panel below).
✓ SEC filings✓ Lobbying registrationpossible match✗ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website
No LEI, no SAM registration, no IRS return, no state registration, no website on record.
Pediatrix Medical Group, Inc. is an SEC-registered operating company in services-hospitals, incorporated in FL, based in Sunrise, FL; listed as MD (NYSE).[source] It reported revenue of $1.91 billion for the fiscal year ended 2025-12-31.[source] It has filed 57 documents with the SEC in the last 12 months; the latest is Form 10-Q, filed 2026-10-29.[source] 4 lobbying disclosure filings name a client with this company's exact name (possible match).[source] Its largest institutional holders on 13F filings are BlackRock, Inc., VANGUARD PORTFOLIO MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP (as of 2026-06-30).[source] 25 of 26 lists and sources checked came back clear; the rest are listed with their result.[source]
- red0
- amber0
- info0
- BlackRock, Inc.$347.4M
- VANGUARD PORTFOLIO MANAGEMENT LLC$151.6M
- DIMENSIONAL FUND ADVISORS LP$106.9M
- VANGUARD CAPITAL MANAGEMENT LLC$91.7M
- STATE STREET CORP$89.5M
- VICTORY CAPITAL MANAGEMENT INC$86.6M
- WASATCH ADVISORS LP$63.3M
- GEODE CAPITAL MANAGEMENT, LLC$56.4M
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Officers and directors (Forms 3, 4, 5)
- Moore Mary Ann E · EVP, GC, Chief Admin Off & Sec (Officer) · latest Form 4 2026-03-03 · filing · LinkedIn search
- Neeb Don Gregory · EVP, Chief Invest & Strategy (Officer) · latest Form 4 2025-08-05 · filing · LinkedIn search
- ORDAN MARK S · Chief Executive Officer (Director,Officer) · latest Form 4 2025-12-17 · filing · LinkedIn search
- Rossi Kasandra H · EVP, CFO and Treasurer (Officer) · latest Form 4 2026-03-03 · filing · LinkedIn search
- Linynsky Laura A · Director · latest Form 4 2025-11-10 · filing · LinkedIn search
- McEachin Thomas · Director · latest Form 4 2025-08-21 · filing · LinkedIn search
- Newman Kurt Douglas · Director · latest Form 4 2025-08-05 · filing · LinkedIn search
- Rucker Michael A. · Director · latest Form 4 2025-11-19 · filing · LinkedIn search
- SANSONE GUY P · Director · latest Form 4 2025-05-12 · filing · LinkedIn search
- Starcher John M. Jr. · Director · latest Form 4 2025-05-12 · filing · LinkedIn search
- Weis Shirley A · Director · latest Form 4 2025-05-27 · filing · LinkedIn search
- Young Sylvia Jean · Director · latest Form 4 2025-05-12 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
Legal counsel, as publicly named
- Sidley Austin LLP · Exhibit 5.1 legal opinion, S-8 filed 2026-05-21
Links
- Official website (Wikidata or the SEC record)
- Wikidata
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 25 CLEAR, 1 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0000893949 | source |
| EIN | 26-3667538 | source |
| LDA clientpossible match | 67104 | record |
| LDA clientpossible match | 200663 | record |
| LDA clientpossible match | 165813 | record |
| Business address (SEC) | 1301 CONCORD TERRACE, SUNRISE, FL, 33323 | source |
Does not exist in the records we hold: LEI, UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-03-01 · in 99 days · Next 10-K due (period ended 2026-12-31; Large accelerated filer) (computed from the fiscal year end and filer status)
- 2027-05-10 · in 169 days · Next 10-Q due (period ended 2027-03-31; Large accelerated filer) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 8060 (services-hospitals): 3 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- Encompass Health Corp · 118 SEC filings in 12 months · 1 flag · $24K federal (possible match)
- Pediatrix Medical Group, Inc. · 58 SEC filings in 12 months
- JRSIS HEALTH CARE Corp · 0 SEC filings in 12 months · 1 flag
SHARED PEOPLE · SHARED ADDRESS
Network neighbours
Shared directors and officers
- CVS HEALTH Corp · Guy P. Sansone
- Carlyle Group Inc. · Mark S. Ordan
- FEDERAL REALTY INVESTMENT TRUST · Thomas A. McEachin
- LINCOLN EDUCATIONAL SERVICES CORP · Sylvia J. Young
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-10-29 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-10-29 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-09-14 filing 144 · SEC EDGAR
- 2026-09-14 filing 144 · SEC EDGAR
- 2026-09-10 filing 144 · SEC EDGAR
- 2026-08-14 filing 144 · SEC EDGAR
- 2026-08-04 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-08-04 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-07-24 officer change 8-K items 5.02,7.01 · SEC EDGAR
- 2026-07-15 filing 8-K items 2.02,7.01,9.01 · SEC EDGAR
- 2026-05-21 filing S-8 · SEC EDGAR
- 2026-05-13 filing 144 · SEC EDGAR
- 2026-05-07 officer change 8-K items 5.02,5.07,9.01 · SEC EDGAR
- 2026-05-05 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-05-05 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-04-17 filing DEFA14A · SEC EDGAR
- 2026-03-27 filing ARS · SEC EDGAR
- 2026-03-27 filing DEFA14A · SEC EDGAR
- 2026-03-27 filing Proxy statement · SEC EDGAR
- 2026-02-19 filing Annual report (10-K) · SEC EDGAR
- 2026-02-19 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2025-12-15 filing 144 · SEC EDGAR
- 2025-11-17 filing 144 · SEC EDGAR
- 2025-11-06 filing 144 · SEC EDGAR
- 2025-11-03 filing Quarterly report (10-Q) · SEC EDGAR
- 2025-11-03 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2025-08-18 filing 8-K items 7.01,8.01,9.01 · SEC EDGAR
- 2025-08-05 filing Quarterly report (10-Q) · SEC EDGAR
- 2025-08-05 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2025-08-05 insider First Form 3/4/5 on record for Neeb Don Gregory (EVP, Chief Invest & Strategy) · SEC Forms 3/4/5
143 earlier entries
- 2025-07-01 officer change 8-K items 5.02,7.01,9.01
- 2025-07-01 insider First Form 3/4/5 on record for Newman Kurt Douglas (Director)
- 2025-06-03 insider First Form 3/4/5 on record for Moore Mary Ann E (EVP, GC, Chief Admin Off & Sec)
- 2025-06-03 insider First Form 3/4/5 on record for Rossi Kasandra H (EVP, CFO and Treasurer)
- 2025-05-12 insider First Form 3/4/5 on record for ORDAN MARK S (Chief Executive Officer)
- 2025-05-12 insider First Form 3/4/5 on record for Linynsky Laura A (Director)
- 2025-05-12 insider First Form 3/4/5 on record for McEachin Thomas (Director)
- 2025-05-12 insider First Form 3/4/5 on record for Rucker Michael A. (Director)
- 2025-05-12 insider First Form 3/4/5 on record for SANSONE GUY P (Director)
- 2025-05-12 insider First Form 3/4/5 on record for Starcher John M. Jr. (Director)
- 2025-05-12 insider First Form 3/4/5 on record for Weis Shirley A (Director)
- 2025-05-12 insider First Form 3/4/5 on record for Young Sylvia Jean (Director)
- 2025-05-08 filing 8-K items 5.07
- 2025-05-06 filing Quarterly report (10-Q)
- 2025-05-06 filing 8-K items 2.02,9.01
- 2025-04-18 filing 8-K items 1.01
- 2025-03-28 filing ARS
- 2025-03-28 filing DEFA14A
- 2025-03-28 filing Proxy statement
- 2025-02-21 filing 144
- 2025-02-20 filing Annual report (10-K)
- 2025-02-20 filing 8-K items 2.02,9.01
- 2025-01-14 officer change 8-K items 5.02
- 2025-01-13 filing 8-K items 2.02,7.01,9.01
- 2024-12-05 officer change 8-K items 5.02
- 2024-11-13 filing 144
- 2024-11-08 filing 144
- 2024-11-04 filing 144
- 2024-11-01 filing Quarterly report (10-Q)
- 2024-11-01 filing 8-K items 2.02,9.01
- 2024-08-30 filing 144
- 2024-08-27 filing 144
- 2024-08-09 filing 144
- 2024-08-09 filing 144
- 2024-08-06 filing Quarterly report (10-Q)
- 2024-08-06 officer change 8-K items 2.02,5.02,9.01
- 2024-06-17 officer change 8-K items 5.02
- 2024-05-30 filing 8-K items 7.01,9.01
- 2024-05-09 filing 8-K items 5.07
- 2024-05-07 filing Quarterly report (10-Q)
- 2024-05-07 filing 8-K items 2.02,9.01
- 2024-04-25 filing 8-K items 1.01
- 2024-03-28 filing ARS
- 2024-03-28 filing DEFA14A
- 2024-03-28 filing Proxy statement
- 2024-02-20 filing Annual report (10-K)
- 2024-02-20 filing 8-K items 2.02,9.01
- 2023-12-14 filing 144
- 2023-11-02 filing Quarterly report (10-Q)
- 2023-11-02 filing 8-K items 2.02,9.01
- 2023-08-16 filing UPLOAD
- 2023-08-08 filing CORRESP
- 2023-08-03 filing Quarterly report (10-Q)
- 2023-08-03 filing 8-K items 2.02,9.01
- 2023-07-27 filing UPLOAD
- 2023-06-14 filing 144
- 2023-05-24 filing 144
- 2023-05-19 filing 144
- 2023-05-18 filing 144
- 2023-05-12 filing 144
- 2023-05-11 filing 8-K items 5.07
- 2023-05-10 filing 144
- 2023-05-04 officer change 8-K items 5.02,7.01,9.01
- 2023-05-02 filing Quarterly report (10-Q)
- 2023-05-02 filing 8-K items 2.02,9.01
- 2023-03-31 filing ARS
- 2023-03-31 filing DEFA14A
- 2023-03-31 filing Proxy statement
- 2023-03-08 officer change 8-K items 5.02
- 2023-02-17 filing Annual report (10-K)
- 2023-02-17 filing 8-K items 2.02,9.01
- 2023-01-20 filing SC 13D/A
- 2022-12-16 officer change 8-K items 5.02,7.01,9.01
- 2022-12-02 filing SC 13D/A
- 2022-11-03 filing Quarterly report (10-Q)
- 2022-11-03 filing 8-K items 2.02,9.01
- 2022-09-23 officer change 8-K items 5.02
- 2022-08-04 filing Quarterly report (10-Q)
- 2022-08-04 filing 8-K items 2.02,9.01
- 2022-06-21 filing 8-K items 7.01,9.01
- 2022-06-21 name change Name changed from MEDNAX, INC.
- 2022-05-17 officer change 8-K items 5.02,5.07
- 2022-04-28 filing Quarterly report (10-Q)
- 2022-04-28 filing 8-K items 2.02,9.01
- 2022-04-01 filing DEFA14A
- 2022-04-01 filing Proxy statement
- 2022-03-21 filing PRE 14A
- 2022-02-25 officer change 8-K items 5.02
- 2022-02-17 filing Annual report (10-K)
- 2022-02-17 filing 8-K items 2.02,9.01
- 2022-02-14 filing 8-K items 1.01,2.03,7.01,9.01
- 2021-11-19 officer change 8-K items 5.02,5.03,8.01,9.01
- 2021-10-28 filing Quarterly report (10-Q)
- 2021-10-28 filing 8-K items 2.02,9.01
- 2021-08-31 filing SC 13D/A
- 2021-08-27 filing 8-K items 8.01
- 2021-08-06 filing S-8
- 2021-08-06 filing S-8
- 2021-08-06 filing Quarterly report (10-Q)
- 2021-08-06 filing 8-K items 2.02,9.01
- 2021-05-17 filing 8-K items 1.01
- 2021-05-14 officer change 8-K items 5.02,5.07,9.01
- 2021-05-07 filing Quarterly report (10-Q)
- 2021-05-07 filing 8-K items 2.02,9.01
- 2021-03-23 filing DEFA14A
- 2021-03-23 filing Proxy statement
- 2021-02-18 filing Annual report (10-K)
- 2021-02-18 filing 8-K items 2.02,9.01
- 2020-12-21 filing 8-K items 2.01,2.04,7.01,8.01,9.01
- 2020-11-24 filing 8-K items 8.01
- 2020-11-06 filing Quarterly report (10-Q)
- 2020-11-06 filing 8-K items 2.02,9.01
- 2020-09-29 officer change 8-K items 5.02
- 2020-09-15 filing 8-K items 1.01,5.07,9.01
- 2020-09-10 filing 8-K items 7.01,8.01,9.01
- 2020-08-25 officer change 8-K items 5.02,7.01,9.01
- 2020-07-30 filing Quarterly report (10-Q)
- 2020-07-30 filing 8-K items 2.02,9.01
- 2020-07-28 filing DEFA14A
- 2020-07-28 filing Proxy statement
- 2020-07-13 filing SC 13D/A
- 2020-07-13 filing DEFA14A
- 2020-07-13 officer change 8-K items 1.01,5.02,7.01,9.01
- 2020-06-15 filing DEFA14A
- 2020-06-15 filing 8-K items 8.01
- 2020-06-05 filing DEFA14A
- 2020-06-05 filing 8-K items 7.01,8.01,9.01
- 2020-05-15 filing SC 13D/A
- 2020-05-12 filing 8-K items 1.01,2.01,9.01
- 2020-05-07 filing Quarterly report (10-Q)
- 2020-05-07 filing 8-K items 2.02,9.01
- 2020-05-06 filing 8-K items 7.01,8.01,9.01
- 2020-04-28 filing 10-K/A
- 2020-04-07 officer change 8-K items 5.02
- 2020-03-25 filing 8-K items 1.01,2.03,7.01,8.01,9.01
- 2020-03-09 filing 8-K items 8.01
- 2020-03-02 filing SC 13D/A
- 2020-02-20 filing 8-K items 2.02,9.01
- 2020-02-20 filing Annual report (10-K)
- 2020-02-18 filing SEC STAFF LETTER
- 2020-02-14 filing DFAN14A
- 2020-02-13 filing SC 13D
- 2009-01-02 name change Name changed from PEDIATRIX MEDICAL GROUP INC
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-10-29 (within 30 days) 10-Q filed
- 2026-10-29 (within 30 days) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-08-04 (older) 10-Q filed
- 2026-08-04 (older) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-07-24 (older) 8-K filed: Item 5.02 officer or director change; Item 7.01 Regulation FD disclosure
- 2026-07-15 (older) 8-K filed: Item 2.02 results of operations; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-05-21 (older) S-8 filed
- 2026-05-07 (older) 8-K filed: Item 5.02 officer or director change; Item 5.07 shareholder vote; Item 9.01 exhibits
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-22; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NYSE:MD The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
6 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 893949 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | MD / NYSE | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| EIN | 263667538 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0000893949 | SEC EDGAR / IRS |
| CUSIP | 58502B106 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0000893949 | SEC EDGAR |
possible match: matched by name only, not merged (4)
Identifiers carried by records that share the company's exact name. Not merged into the identity above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| LDA client id | 179839 (PEDIATRIX MEDICAL GROUP INC (lobbying via BLOSSER & SAYFIE)) | name-exact:legal-name: same registered legal name as 'Pediatrix Medical Group, Inc.' | Lobbying Disclosure Act (LDA) |
| LDA client id | 67104 (PEDIATRIX MEDICAL GROUP INC (lobbying via CARMEN GROUP INCORPORATED)) | name-exact:legal-name: same registered legal name as 'Pediatrix Medical Group, Inc.' | Lobbying Disclosure Act (LDA) |
| LDA client id | 165813 (PEDIATRIX MEDICAL GROUP, INC. (lobbying via AVENUE SOLUTIONS)) | name-exact:legal-name: same registered legal name as 'Pediatrix Medical Group, Inc.' | Lobbying Disclosure Act (LDA) |
| LDA client id | 200663 (PEDIATRIX MEDICAL GROUP, INC. (lobbying via PEDIATRIX MEDICAL GROUP, INC.)) | name-exact:legal-name: same registered legal name as 'Pediatrix Medical Group, Inc.' | Lobbying Disclosure Act (LDA) |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Revenue (fiscal year ended 2025-12-31) | $1,913,849,000 | 2025-12-31 | 10-K, XBRL RevenueFromContractWithCustomerIncludingAssessedTax | as filed | 2026-11-22 00:39 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | $165,388,000 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-22 00:39 UTC | Report an error |
| Total assets (at 2025-12-31) | $2,246,696,000 | 2025-12-31 | 10-K, XBRL Assets | as filed | 2026-11-22 00:39 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $865,854,000 | 2025-12-31 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-22 00:39 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $375,241,000 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-22 00:39 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-10-29 | SEC EDGAR company profile | as filed | 2026-11-22 00:39 UTC | Report an error |
| SIC industry | 8060 Services-Hospitals | 2026-10-29 | SEC EDGAR company profile | as filed | 2026-11-22 00:39 UTC | Report an error |
| State of incorporation | FL | 2026-10-29 | SEC EDGAR company profile | as filed | 2026-11-22 00:39 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-10-29 | SEC EDGAR company profile | as filed | 2026-11-22 00:39 UTC | Report an error |
| Business address | 1301 CONCORD TERRACE, SUNRISE, FL, 33323 | 2026-10-29 | SEC EDGAR company profile | as filed | 2026-11-22 00:39 UTC | Report an error |
| Exchanges | NYSE | 2026-10-29 | SEC EDGAR company profile | as filed | 2026-11-22 00:39 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2025-12-31) | $271,091,000 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-22 00:39 UTC | Report an error |
| Long-term debt (at 2024-12-31) | $611,200,000 | 2024-12-31 | 10-K, XBRL LongTermDebt | as filed | 2026-11-22 00:39 UTC | Report an error |
| Operating lease liabilities (at 2025-12-31) | $37,277,000 | 2025-12-31 | 10-K, XBRL OperatingLeaseLiability | as filed | 2026-11-22 00:39 UTC | Report an error |
| Form D total offering amount (D filed 2017-12-01) | $45,000,000 | 2017-12-01 | D | as filed | 2026-11-22 00:39 UTC | Report an error |
| Form D total amount sold (D filed 2017-12-01) | $2,144,680 | 2017-12-01 | D | as filed | 2026-11-22 00:39 UTC | Report an error |
| Form D industry group | Hospitals and Physicians | 2017-12-01 | D | as filed | 2026-11-22 00:39 UTC | Report an error |
| Form D revenue range | Over $100,000,000 | 2017-12-01 | D | as filed | 2026-11-22 00:39 UTC | Report an error |
| Form D date of first sale | 2017-10-17 | 2017-12-01 | D | as filed | 2026-11-22 00:39 UTC | Report an error |
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-10-29 · accession 0001193125-26-436952
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Revenue | $501,374,000 | 3 months ended 2026-09-30 | 10-Q | 2026-10-29 | 0001193125-26-436952 | 2026-11-22 00:39 UTC | Report an error |
| Net income (loss) | $46,991,000 | 3 months ended 2026-09-30 | 10-Q | 2026-10-29 | 0001193125-26-436952 | 2026-11-22 00:39 UTC | Report an error |
| Interest expense | $8,127,000 | 3 months ended 2026-09-30 | 10-Q | 2026-10-29 | 0001193125-26-436952 | 2026-11-22 00:39 UTC | Report an error |
| Cash and cash equivalents | $311,916,000 | at 2026-09-30 | 10-Q | 2026-10-29 | 0001193125-26-436952 | 2026-11-22 00:39 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-10-29 Filing 10-Q filed
- 2026-10-29 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-08-04 Filing 10-Q filed
- 2026-08-04 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-07-24 Filing 8-K filed: Item 5.02 officer or director change; Item 7.01 Regulation FD disclosure
- 2026-07-15 Filing 8-K filed: Item 2.02 results of operations; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-05-21 Filing S-8 filed
- 2026-05-07 Filing 8-K filed: Item 5.02 officer or director change; Item 5.07 shareholder vote; Item 9.01 exhibits
- 2026-05-05 Filing 10-Q filed
- 2026-05-05 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-04-17 Filing DEFA14A filed
- 2026-03-27 Filing ARS filed
- 2026-03-27 Filing DEFA14A filed
- 2026-03-27 Filing DEF 14A filed
- 2026-02-19 Filing 10-K filed
- 2026-02-19 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2025-11-03 Filing 10-Q filed
- 2025-11-03 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2025-08-18 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 8.01 other event; Item 9.01 exhibits
- 2025-08-05 Filing 10-Q filed
- 2025-08-05 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2025-07-01 Filing 8-K filed: Item 5.02 officer or director change; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2025-05-08 Filing 8-K filed: Item 5.07 shareholder vote
- 2025-05-06 Filing 10-Q filed
- 2025-05-06 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
8-K item text, as filed (excerpts)
- 2026-10-29 8-K Item 2.02, Results of Operations and Financial Condition
On October 29, 2026, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), issued a press release announcing the results of its operations for the three and nine months ended September 30, 2026 (the “Third Quarter Release”). A copy of the Third Quarter Release is attached hereto as Exhibit 99.1 and is hereby incorporated in this Current Report by reference. The information contained in this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” with the Securities and Exchange Commission nor incorporated by reference in any registration statement or other document filed by the Company under the Securities Act of 1933, as amended, except as shall be expressly set… the 8-K · retrieved 2026-11-22 00:39 UTC - 2026-08-04 8-K Item 2.02, Results of Operations and Financial Condition
On August 4, 2026, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), issued a press release announcing the results of its operations for the three and six months ended June 30, 2026 (the “Second Quarter Release”). A copy of the Second Quarter Release is attached hereto as Exhibit 99.1 and is hereby incorporated in this Current Report by reference. The information contained in this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” with the Securities and Exchange Commission nor incorporated by reference in any registration statement or other document filed by the Company under the Securities Act of 1933, as amended, except as shall be expressly set forth by… the 8-K · retrieved 2026-11-22 00:39 UTC
Each excerpt is the first part of the item's own text, copied as filed and cut at a word; the filing has the rest.
POSSIBLE MATCHES · NAME ONLY6. Lobbying (LDA)
4 lobbying records carry this company's exact name, hiring 4 lobbying firms. These are possible matches until the accuracy score, so they are not counted in the headline.
possible match: matched by name only, not merged (4)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchPEDIATRIX MEDICAL GROUP INC (lobbying via BLOSSER & SAYFIE) · exact legal name · sx:lda:179839 Compare
- possible matchPEDIATRIX MEDICAL GROUP INC (lobbying via CARMEN GROUP INCORPORATED) · exact legal name · sx:lda:67104 Compare
- possible matchPEDIATRIX MEDICAL GROUP, INC. (lobbying via AVENUE SOLUTIONS) · exact legal name · sx:lda:165813 Compare
- possible matchPEDIATRIX MEDICAL GROUP, INC. (lobbying via PEDIATRIX MEDICAL GROUP, INC.) · exact legal name · sx:lda:200663 Compare
POSSIBLE MATCHES · GROUPED BY SOURCE8. Enforcement by agency
SEC litigation (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchPediatrix Medical Group, Inc. · exact legal name · sx:seclit:LR-20927 Compare
Each record's own page holds its date and the agency document. Matched by exact name only; none of these is counted in the headline.
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | $347,382,597 | 2026-06-30 | SEC 13F filing | 2026-11-22 00:39 UTC | Report an error |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | $151,603,774 | 2026-06-30 | SEC 13F filing | 2026-11-22 00:39 UTC | Report an error |
| 3 | DIMENSIONAL FUND ADVISORS LP | $106,895,973 | 2026-06-30 | SEC 13F filing | 2026-11-22 00:39 UTC | Report an error |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | $91,695,613 | 2026-06-30 | SEC 13F filing | 2026-11-22 00:39 UTC | Report an error |
| 5 | STATE STREET CORP | $89,497,172 | 2026-06-30 | SEC 13F filing | 2026-11-22 00:39 UTC | Report an error |
| 6 | VICTORY CAPITAL MANAGEMENT INC | $86,550,406 | 2026-06-30 | SEC 13F filing | 2026-11-22 00:39 UTC | Report an error |
| 7 | WASATCH ADVISORS LP | $63,296,732 | 2026-06-30 | SEC 13F filing | 2026-11-22 00:39 UTC | Report an error |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | $56,395,339 | 2026-06-30 | SEC 13F filing | 2026-11-22 00:39 UTC | Report an error |
| 9 | AMERICAN CENTURY COMPANIES INC | $55,523,802 | 2026-06-30 | SEC 13F filing | 2026-11-22 00:39 UTC | Report an error |
| 10 | FULLER & THALER ASSET MANAGEMENT, INC. | $43,604,361 | 2026-06-30 | SEC 13F filing | 2026-11-22 00:39 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS13. Permits and local records
1 state and city record carry this company's exact name, from 1 source. Possible matches only.
State spending (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchPEDIATRIX MEDICAL GROUP · exact name match to 'Pediatrix Medical Group, Inc.' (no other entity shares the name) · sx:espend:mdp:a5fc205053598cd8 Compare
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/893949.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0000893949. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.